Silk Fiber Films for Controlled Release of Tetracycline and Doxycycline
Objectives: To assess the potential use of silk-based films for the controlled release of tetracycline and doxycycline for localized and continuous delivery of antibiotics during periodontal and oral surgeries. Methods: Tetracycline and doxycycline were mixed, at various concentrations, with silk solution. Antibiotic loaded silk films were incubated with Streptococcus mutans (S. mutans) cultures to assess the release of the antibiotics. Chlorhexidine was used as a positive control and plain silk films without antibiotic as a negative control. Inhibition of bacterial growth was measured spectrophotometrically after each consecutive 24-hour incubation period. The number of colony forming units (CFUs) was determined to validate the growth inhibition. Results: Tetracycline and doxycycline-loaded silk films inhibited S. mutans growth in a concentration and time-dependent manner. Tetracycline with the concentrations of 0.375, 0.75 and 1.5 mg/mL inhibited S. mutans growth up to three, four and five days, respectively (n=4). Doxycycline with the concentrations of 0.375, 0.75 and 1.5 mg/mL inhibited S. mutans growth up to six, ten and eleven days, respectively (n=4). The colony forming units for the 1.5 mg/mL doxycycline and tetracycline exposed S. mutans cultures were 1.2x106 and 1.8x106 CFUs/mL, respectively, which are less compared to the uninhibited control cultures which contained 3.5x109 CFUs/mL. Conclusions: We concluded that tetracycline and doxycycline can be successfully loaded into silk films and can significantly inhibit bacterial growth up to five days for tetracycline and eleven days for doxycycline. Our data support the use of antibiotic loaded silk films for localized and continuous delivery of antibiotics during periodontal and oral surgeries, thus minimizing risks associated with oral delivery of antibiotics.
Division:IADR/AADR/CADR General Session
Meeting:2020 IADR/AADR/CADR General Session (Washington, D.C., USA) Location:Washington, D.C., USA
Year: 2020 Final Presentation ID:0895 Abstract Category|Abstract Category(s):Oral Health Research
Authors
Foroutanjazi, Sadaf
( Tufts University School of Dental Medicine
, Boston
, Massachusetts
, United States
)
Ghezzi, Chiara E.
( Tufts University School of Dental Medicine
, Boston
, Massachusetts
, United States
)
Kaplan, David L.
( Tufts University School of Dental Medicine
, Boston
, Massachusetts
, United States
)
Kugel, Gerard
( Tufts University School of Dental Medicine
, Boston
, Massachusetts
, United States
)
Zoukhri, Driss
( Tufts University School of Dental Medicine
, Boston
, Massachusetts
, United States
)
Financial Interest Disclosure: NONE
SESSION INFORMATION
Poster Session
Novel Technologies & Techniques to Assess Efficacy